CXCL8 and prostate carcinoma: Hence, blockade of NF-κB was reported to inhibit in vitro and in vivo expression of vascular endothelial growth factor (VEGF), MMP-9 and interleukin-8 (IL-8) and consequently decreased neoplastic angiogenesis in human prostate cancer cells52.